Opuviz
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Opuviz, covering 2026-01-19 to 2026-07-03. Get the full timeline:
Most recent: EMA Authorised: Opuviz (aflibercept) — Samsung Bioepis NL B.V.
2 regulatory and trial events tracked for Opuviz, covering 2026-01-19 to 2026-07-03. Get the full timeline:
Most recent: EMA Authorised: Opuviz (aflibercept) — Samsung Bioepis NL B.V.